MoneyWorks4Me

Shree Ganesh Remedies gets nod for migrating Shares from SME platform to BSE

24 Nov 2020 Evaluate

Shree Ganesh Remedies has received approval from BSE for migrating the 10,006,446 Equity Shares of the Company from SME platform to Main Board platform of BSE with effective from November 25, 2020.

Shree Ganesh Remedies is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..